Krystal Biotech buy The Goldman Sachs Group, Inc.
Start price
30.01.26
/
50%
€237.90
Target price
30.01.27
-
Performance (%)
2.94%
Price
18:03
€244.90
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr shows slight gains of 2.94%. This prediction currently runs until 30.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Krystal Biotech | 6.907% |
| iShares Core DAX® | -0,82 % |
| iShares Nasdaq 100 | -1,74 % |
| iShares Nikkei 225® | 1,21 % |
| iShares S&P 500 | -1,17 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for KRYS provided by MarketBeat